Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

NCT00245648 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: fibrinolytic therapy or combination reduced fibrinolytic therapy

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]
[object Object]